Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona.
Zanelli S, Fiorio E, Zampiva I, Zacchi F, Borghesani G, Giontella E, Parolin V, Biondani P, Zuliani S, Dieci MV, Mioranza E, Zorzi M, Conti M, Gibellini D, Verlato G, Milella M. Zanelli S, et al. Among authors: parolin v. Ann Oncol. 2022 Jun;33(6):661-663. doi: 10.1016/j.annonc.2022.02.227. Epub 2022 Mar 9. Ann Oncol. 2022. PMID: 35276335 Free PMC article. No abstract available.
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.
Zambonin V, De Toma A, Carbognin L, Nortilli R, Fiorio E, Parolin V, Pilotto S, Cuppone F, Pellini F, Lombardi D, Pollini GP, Tortora G, Bria E. Zambonin V, et al. Among authors: parolin v. Expert Opin Biol Ther. 2017 Apr;17(4):497-506. doi: 10.1080/14712598.2017.1289171. Epub 2017 Feb 13. Expert Opin Biol Ther. 2017. PMID: 28133971 Review.
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation.
Carbognin L, Sperduti I, Fabi A, Dieci MV, Kadrija D, Griguolo G, Pilotto S, Guarneri V, Zampiva I, Brunelli M, Orvieto E, Nortilli R, Fiorio E, Parolin V, Manfrin E, Caliò A, Nisticò C, Pellini F, Scarpa A, Pollini GP, Conte P, Tortora G, Bria E. Carbognin L, et al. Among authors: parolin v. Breast. 2017 Oct;35:21-26. doi: 10.1016/j.breast.2017.06.005. Epub 2017 Jun 17. Breast. 2017. PMID: 28628772
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
Zuliani S, Zampiva I, Tregnago D, Casali M, Cavaliere A, Fumagalli A, Merler S, Riva ST, Rossi A, Zacchi F, Zaninotto E, Auriemma A, Pavarana M, Soldà C, Benini L, Borghesani M, Caldart A, Casalino S, Gaule M, Kadrija D, Mongillo M, Pesoni C, Biondani P, Cingarlini S, Fiorio E, Melisi D, Parolin V, Tondulli L, Belluomini L, Zecchetto C, Avesani B, Biasi A, Bovo C, Dazzani E, Dodi A, Gelmini S, Leta LC, Lo Cascio G, Lombardo F, Lucin E, Martinelli IA, Messineo L, Moscarda V, Pafumi S, Reni A, Sartori G, Scaglione IM, Shoval Y, Sposito M, Tacconelli E, Trestini I, Zambonin V, Zanelli S, Pilotto S, Milella M. Zuliani S, et al. Among authors: parolin v. Eur J Cancer. 2020 Aug;135:159-169. doi: 10.1016/j.ejca.2020.05.029. Epub 2020 Jun 11. Eur J Cancer. 2020. PMID: 32580131 Free PMC article.
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study.
Trestini I, Sperduti I, Caldart A, Bonaiuto C, Fiorio E, Parolin V, Zambonin V, Zanelli S, Tregnago D, Avancini A, Cintoni M, Pilotto S, Mele MC, Gasbarrini A, Scambia G, Milella M, Tortora G, Bria E, Carbognin L. Trestini I, et al. Among authors: parolin v. Breast. 2021 Dec;60:6-14. doi: 10.1016/j.breast.2021.08.008. Epub 2021 Aug 21. Breast. 2021. PMID: 34454324 Free PMC article.
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer.
Trestini I, Caldart A, Cintoni M, Sperduti I, Drudi A, Aluffi G, Fiorio E, Parolin V, Zambonin V, Zanelli S, Tregnago D, Avancini A, Pilotto S, Aprili I, Zandonà E, D'Onofrio M, Mele MC, Gasbarrini A, Scambia G, Tortora G, Milella M, Bria E, Carbognin L. Trestini I, et al. Among authors: parolin v. Nutrition. 2023 Jan;105:111858. doi: 10.1016/j.nut.2022.111858. Epub 2022 Oct 1. Nutrition. 2023. PMID: 36323147
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Fontanella C, Giorgi CA, Russo S, Angelini S, Nicolardi L, Giarratano T, Frezzini S, Pestrin M, Palleschi D, Bolzonello S, Parolin V, Haspinger ER, De Rossi C, Greco F, Gerratana L. Fontanella C, et al. Among authors: parolin v. Crit Rev Oncol Hematol. 2022 Dec;180:103848. doi: 10.1016/j.critrevonc.2022.103848. Epub 2022 Oct 17. Crit Rev Oncol Hematol. 2022. PMID: 36257536 Free article. Review.
EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.
Biganzoli L, Cinieri S, Berardi R, Pedersini R, McCartney A, Minisini AM, Caremoli ER, Spazzapan S, Magnolfi E, Brunello A, Risi E, Palumbo R, Leo S, Colleoni M, Donati S, De Placido S, Orlando L, Pistelli M, Parolin V, Mislang A, Becheri D, Puglisi F, Sanna G, Zafarana E, Boni L, Mottino G. Biganzoli L, et al. Among authors: parolin v. Breast Cancer Res. 2020 Aug 5;22(1):83. doi: 10.1186/s13058-020-01319-1. Breast Cancer Res. 2020. PMID: 32758299 Free PMC article. Clinical Trial.
13 results